Skip to main content
. 2008 Feb 19;18(2):146–152. doi: 10.1007/s10165-008-0026-3

Fig. 1.

Fig. 1

Continuation of the infliximab therapy in RA patients for 54 weeks. a Survival rate of RA patients treated with infliximab (n = 410, total and three institutes) during the 54-week therapy. b Cumulative hazards of the discontinuation of infliximab therapy by week 54 of the treatment